Balchem Corporation (BCPC) Q4 2025 Earnings Call Transcript

Stock News Oil climbs on Iran risk: Crude headed for its first weekly gain in three weeks as tensions rose over potential U.S. strikes on Iran and possible Stra

MONTVALE, N.J., Feb. 20, 2026 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC) reported today financial results for its 2025 fiscal fourth quarter and full year ended December 31, 2025.

MONTVALE, N.J., Feb. 06, 2026 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC) today announced that a conference call will be held on Friday, February 20, 2026, at 11:00 AM Eastern Time (ET) to review fourth quarter and full year 2025 results.

MONTVALE, N.J., Dec. 22, 2025 (GLOBE NEWSWIRE) -- As producers of choline chloride in the EU, Eastman and Balchem welcome the European Union's decision published on December 19, 2025 to adopt anti-dumping duties between 90.0 and 115.9% on choline chloride imports from the People's Republic of China.

David B Fischer directly sold 8,000 shares for a total of ~$1,231,748 on Dec. 3, 2025, at a weighted average price of around $154 per share. This transaction reduced his direct holdings by 50%, leaving him with 7,989 shares.

MONTVALE, N.J., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC), a global specialty ingredient manufacturer for health and nutrition markets, announced they will present at Baird's 55th Annual Global Industrial Conference on November 12, 2025.

I raise my rating for Balchem from "Hold" to "Buy," following my assessment of its performance and prospects. BCPC's 3Q2025 financials exceeded expectations, thanks to the strong showing from its Human Nutrition and Specialty Products segments. I'm anticipating that Balchem can realize growth acceleration in the mid-term by capitalizing on emerging food trends, a new production plant, and promising regulatory developments.

Balchem Corporation (NASDAQ:BCPC ) Q3 2025 Earnings Call October 21, 2025 11:00 AM EDT Company Participants Carl Bengtsson - Executive VP, CFO, Treasurer and GM of Animal Nutrition & Health Theodore Harris - CEO, President & Chairman Conference Call Participants Bob Labick - CJS Securities, Inc. Raghuram Selvaraju - H.C. Wainwright & Co, LLC, Research Division Daniel Harriman - Sidoti & Company, LLC Presentation Operator Thank you for standing by.

Balchem (BCPC) came out with quarterly earnings of $1.35 per share, missing the Zacks Consensus Estimate of $1.36 per share. This compares to earnings of $1.03 per share a year ago.